Adults 18 to 70, any sex, with Gingival Recession or Palate; Wound. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Pain Assessment (0=No Pain to 10=Worst)Primary· day 14
To assess the pain outcomes using the visual analog scale from 0=No pain to 10=worst, excrutiating pain. Assessed daily from days 1 to 14, Day 14 reported.
Group
Value
95% CI
Collagen Plug With Sutures
4.2
± 2.4
Platelet Rich Fibrin (PRF)
1.9
± 2.1
Collagen Plug With Cyanoacrylate (CPC)
2.2
± 2.5
Palatal Stent
1
± 1.4
Bleeding AssessmentPrimary· day 14
To assessed the bleeding outcomes using the visual analog scale (VAS) from 0=No bruising/bleeding to 10=severe bruising/bleeding. Assessed daily from days 1 to 14, Day 14 reported.
Group
Value
95% CI
Collagen Plug With Sutures
1
± 1.9
Platelet Rich Fibrin (PRF)
0.6
± 1.4
Collagen Plug With Cyanoacrylate (CPC)
0.9
± 1.9
Palatal Stent
0.7
± 1.6
Activity ToleranceSecondary· day 14
To assess the effects on daily activities using the visual analog scale from 0=No Limitation to 10= Bedrest required. Assessed daily from days 1 to 14, Day 14 reported.
Group
Value
95% CI
Collagen Plug With Sutures
2.4
± 2.4
Platelet Rich Fibrin (PRF)
1.5
± 2.1
Collagen Plug With Cyanoacrylate (CPC)
1.8
± 2.4
Palatal Stent
1.3
± 1.8
Amount of SwellingSecondary· day 14
To assessed the swelling outcomes using the visual scale (VAS) from 0=No swelling to 10=severe swelling. Assessed daily from days 1 to 14, Day 14 reported.
Group
Value
95% CI
Collagen Plug With Sutures
2.2
± 2.4
Platelet Rich Fibrin (PRF)
1.3
± 1.9
Collagen Plug With Cyanoacrylate (CPC)
1.4
± 2
Palatal Stent
1.3
± 2
The Need for PainkillerSecondary· day 14
To assess the needs for the painkiller using the visual analog scale (VAS). (0 = No painkiller needed to 10 = Needed painkiller). Assessed daily from days 1 to 14, Day 14 reported.
Group
Value
95% CI
Collagen Plug With Sutures
2.1
± 2.5
Platelet Rich Fibrin (PRF)
2
± 2.6
Collagen Plug With Cyanoacrylate (CPC)
2.2
± 2.8
Palatal Stent
1.5
± 1.8
Sponsor's own description
This randomized clinical comparative study will evaluate the postoperative pain following the FGG graft harvest procedure technique covered by four different methods for coverage of the palatal donor site.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07513792 — The Impact of a 3D Imaging Tool on Reducing Gum Recession During Orthodontic Treatment With Aligners
· NA
· recruiting
NCT07437417 — A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth
· NA
· recruiting
NCT07158541 — Comparing TCAF and MTUN With Soft Tissue Grafting for Treating Single Recessions in the Premandible
· NA
· recruiting
NCT07104019 — Biofiller and Gingival Phenotype Thickening
· NA
· recruiting
NCT07291583 — Hyaluronic Acid With Connective Tissue Grafting for Gingival Recession
· NA
· active not recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis
· NA
· not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis
· NA
· withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis
· NA
· not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine
· Phase 2
· not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit
· Phase 2
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 23 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03895476.